Table 1.
Patient characteristics of included patients
| N (%) | ||
|---|---|---|
| Age | Median (IQR) | 65 (55–72) |
| ≤ 60 years | 97 (33) | |
| > 60 years | 199 (67) | |
| Sex | Male | 152 (51) |
| Female | 144 (49) | |
| Ann Arbor stage | II | 48 (16) |
| III | 62 (21) | |
| IV | 186 (63) | |
| LDH | normal | 97 (33) |
| > normal | 199 (67) | |
| Extranodal localisations | ≤ 1 | 175 (59) |
| > 1 | 121 (41) | |
| WHO performance status | 0 | 170 (57) |
| 1 | 87 (29) | |
| 2 | 37 (13) | |
| missing | 2 (1) | |
| IPI | Low | 48 (16) |
| Low-intermediate | 73 (25) | |
| High-intermediate | 103 (35) | |
| High | 72 (24) | |
Abbreviations: LDH, lactate dehydrogenase; WHO, World Health Organization; IPI, international prognostic index